GITNUXREPORT 2026

Medical Research Statistics

Global medical research funding is vast, driving significant advances in treatments and saving countless lives.

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

In 2022, there were 4,568 clinical trials registered on ClinicalTrials.gov actively recruiting participants worldwide.

Statistic 2

Phase III trials for oncology drugs averaged 1,200 patients per trial in 2021-2022, per FDA data.

Statistic 3

COVID-19 vaccine trials enrolled over 150,000 participants across 40 Phase III studies by end of 2021.

Statistic 4

In 2023, 1,200 new interventional trials for rare diseases were initiated globally.

Statistic 5

U.S. FDA approved 37 novel drugs in 2022 from pivotal trials, 50% oncology.

Statistic 6

Average duration of Phase II trials increased to 3.2 years in 2020-2022 due to complexity.

Statistic 7

Over 90% of trials in 2022 used electronic data capture systems, reducing errors by 40%.

Statistic 8

Diversity in trials: Only 8% of participants in CAR-T cell therapy trials were Black in 2017-2022.

Statistic 9

Global trial sites numbered 200,000 in 2022, with 40% in North America.

Statistic 10

Adaptive trial designs used in 15% of new oncology trials in 2022.

Statistic 11

Pediatric trials: Only 12% of drugs approved 2012-2022 had pediatric-specific trials.

Statistic 12

Decentralized trials grew to 20% of all trials in 2023, per Clinical Leader survey.

Statistic 13

Alzheimer's trials failed at 99% rate over 20 years, with 200+ terminated by 2023.

Statistic 14

mRNA platform trials accelerated: 10 vaccines in Phase III within 1 year for COVID.

Statistic 15

In 2022, 2,500 trials focused on gene therapy, up 300% since 2015.

Statistic 16

Trial recruitment time averaged 4.5 months in 2022, down 20% from 2019 via tech.

Statistic 17

EU Clinical Trials Regulation: 4,800 trials authorized in first year post-2022.

Statistic 18

Biosimilar trials: 150 ongoing in 2023 for monoclonal antibodies.

Statistic 19

Heart failure trials: 500 active in 2023, focusing on SGLT2 inhibitors.

Statistic 20

Only 5% of trials in low-income countries in 2022, per WHO.

Statistic 21

AI predicted trial outcomes in 80% accuracy for 1,000+ trials in 2022 study.

Statistic 22

Rheumatology trials: 300 Phase III in 2022 for JAK inhibitors.

Statistic 23

Long COVID trials: 200 registered by mid-2023.

Statistic 24

Precision medicine trials: 40% enrollment via biomarkers in oncology 2022.

Statistic 25

Vaccine trials for HIV: 50 Phase II/III ongoing in 2023.

Statistic 26

In fiscal year 2023, the U.S. National Institutes of Health (NIH) had a total budget of $47.7 billion, with $36.9 billion allocated directly to extramural research grants supporting over 50,000 competing and non-competing awards.

Statistic 27

The global pharmaceutical R&D expenditure reached $238 billion in 2022, marking a 5.3% increase from the previous year, led by top 20 companies investing 19% of their sales revenue.

Statistic 28

In 2021, the European Union allocated €95.5 billion to Horizon Europe, with €7.7 billion specifically for health cluster research including medical innovation.

Statistic 29

Cancer research funding in the U.S. totaled $6.8 billion in 2022 from NIH, representing 13% of the total NIH extramural budget.

Statistic 30

Venture capital investment in biotech reached $48.7 billion globally in 2021, a record high with 25% directed towards early-stage medical research firms.

Statistic 31

The Wellcome Trust disbursed £1.2 billion in 2022 for medical research grants, focusing on infectious diseases and mental health.

Statistic 32

U.S. federal funding for Alzheimer's disease research increased to $3.8 billion in FY2023, up 7% from prior year via NIH and other agencies.

Statistic 33

Japan's Ministry of Health, Labour and Welfare budgeted ¥167.4 billion for medical research in 2022, emphasizing regenerative medicine.

Statistic 34

Global R&D funding for rare diseases hit $4.5 billion in 2021 from public and private sources, per the EveryLife Foundation.

Statistic 35

Bill & Melinda Gates Foundation committed $8.6 billion in 2022, with 40% to global health research including vaccines.

Statistic 36

NIH's BRAIN Initiative received $712 million in FY2023 for neuroscience research funding.

Statistic 37

UK Medical Research Council awarded £1.1 billion in 2022-23 for biomedical research across 5,000 projects.

Statistic 38

China's National Natural Science Foundation funded ¥30.6 billion for health sciences in 2022.

Statistic 39

Australian NHMRC invested AUD 1.2 billion in 2022 for medical research grants.

Statistic 40

Howard Hughes Medical Institute provided $800 million annually for biomedical research investigators.

Statistic 41

Global funding for COVID-19 research exceeded $100 billion by 2022, per WHO tracking.

Statistic 42

U.S. DOD funded $1.5 billion for medical research in 2023, including trauma and infectious diseases.

Statistic 43

Canada's CIHR budget was CAD 1.3 billion in 2022-23 for health research.

Statistic 44

Germany's DFG allocated €3.8 billion total in 2022, with 25% to life sciences.

Statistic 45

France's ANR funded €1.1 billion for research, 15% health-related in 2022.

Statistic 46

Philanthropic funding for medical research in U.S. totaled $5.2 billion in 2021 from top 50 donors.

Statistic 47

NIH diversity supplements awarded $100 million in 2022 to support underrepresented researchers.

Statistic 48

ARPA-H launched with $1 billion initial funding in 2022 for high-risk medical research.

Statistic 49

Swiss National Science Foundation allocated CHF 600 million for medicine in 2022.

Statistic 50

India's DBT budgeted INR 4,500 crore for biotech and medical research in 2023-24.

Statistic 51

South Korea's NRF funded KRW 2.5 trillion total, 20% health in 2022.

Statistic 52

Brazil's CNPq invested BRL 1.2 billion for health research in 2022.

Statistic 53

NIH's ORIP funded $200 million for animal models in research in FY2023.

Statistic 54

Global venture funding for AI in drug discovery hit $5.1 billion in 2022.

Statistic 55

U.S. states provided $2.3 billion in bonds for medical research facilities in 2022.

Statistic 56

U.S. medical research saved 100 million life-years from 1990-2020.

Statistic 57

Cancer mortality dropped 33% in U.S. 1991-2022 due to research advances.

Statistic 58

Vaccines prevented 154 million deaths globally 1974-2024.

Statistic 59

HIV treatments extended life expectancy by 10 years post-1996 ART.

Statistic 60

mRNA vaccines reduced COVID deaths by 20 million in first year.

Statistic 61

Statins prevented 100,000 heart attacks annually worldwide by 2020.

Statistic 62

CRISPR gene editing treated first sickle cell patient in 2023 trial.

Statistic 63

Immunotherapy doubled 5-year survival for melanoma from 25% to 50% 2010-2022.

Statistic 64

Global DALYs reduced 20% for infectious diseases 2000-2019 via research.

Statistic 65

Alzheimer's research diagnostics improved detection by 90% accuracy.

Statistic 66

Organoid models accelerated drug discovery, cutting costs 30%.

Statistic 67

CAR-T therapy cured 50% pediatric leukemia cases post-2017.

Statistic 68

Precision oncology matched therapies for 40% advanced cancers 2022.

Statistic 69

Telemedicine research expanded access, reducing no-shows 25%.

Statistic 70

Antibiotic stewardship programs cut resistance 17% in hospitals.

Statistic 71

Mental health apps from research helped 20 million users 2022.

Statistic 72

Regenerative medicine restored vision in 1,000 AMD patients via stem cells.

Statistic 73

Big data analytics predicted outbreaks, saving $1B in response costs.

Statistic 74

HPV vaccine prevented 90% cervical cancers in vaccinated cohorts.

Statistic 75

Robotic surgery reduced complications 20% in 1 million procedures.

Statistic 76

Microbiome research led to 10 new therapeutics in pipeline 2023.

Statistic 77

AI diagnostics matched radiologists 95% accuracy, speeding reports 30%.

Statistic 78

Rare disease research diagnosed 5,000 via genomics 2022.

Statistic 79

Opioid crisis research cut overdose deaths 10% via naloxone.

Statistic 80

Climate-health research informed policies averting 250,000 deaths by 2030.

Statistic 81

Economic return: $1 NIH funding yields $2.21 health gains.

Statistic 82

In 2022, PubMed indexed 1.4 million biomedical research articles, up 4% from 2021.

Statistic 83

Nature Medicine published 1,200 original research papers in 2022 on clinical advances.

Statistic 84

Global scientific output in medical research grew to 2.5 million papers annually by 2023.

Statistic 85

Lancet journals issued 15,000 articles in 2022, with 30% on global health.

Statistic 86

NEJM acceptance rate for original articles was 7.5% in 2022 from 5,000 submissions.

Statistic 87

Open access medical papers reached 50% of total output in 2022, per DOAJ.

Statistic 88

Citations to COVID-19 papers exceeded 1 million by 2022 in Web of Science.

Statistic 89

JAMA Network published 4,500 research articles in 2022.

Statistic 90

h-index for top medical journals averaged 250 in 2023 Scimago rankings.

Statistic 91

Preprints in medRxiv totaled 45,000 in 2022, accelerating dissemination.

Statistic 92

BMJ published 3,200 original research papers in 2022.

Statistic 93

PLOS Medicine impact factor hit 11.1 in 2022 with 400 articles.

Statistic 94

Cell journal family output: 800 medical papers in 2022.

Statistic 95

Science Translational Medicine: 500 articles in 2022 on bench-to-bedside.

Statistic 96

Annual Review of Pathology: 25 reviews in 2022 cited 10,000+ times.

Statistic 97

Retractions in medical journals rose to 2,500 in 2022, per Retraction Watch.

Statistic 98

Altmetric scores for top 100 medical papers averaged 1,500 in 2022.

Statistic 99

Cochrane Reviews updated 1,000 systematic reviews in 2022.

Statistic 100

Nature Reviews series published 2,000 review articles in medicine 2022.

Statistic 101

UpToDate synthesized 12,000 medical topics from 8 million references in 2023.

Statistic 102

Google Scholar indexed 10 million medical citations added in 2022.

Statistic 103

Springer Nature medical portfolio: 25,000 chapters/books in 2022.

Statistic 104

Elsevier's Lancet Digital Health: 300 articles on AI in 2022.

Statistic 105

Citations per medical paper averaged 25 in 2022 Scopus data.

Statistic 106

Women authored 45% of first-author papers in medical journals 2022.

Statistic 107

Medical AI papers surged 300% to 15,000 in PubMed 2020-2022.

Statistic 108

Global health papers: 100,000 in 2022, led by LMICs.

Statistic 109

In 2022, U.S. had 120,000 biomedical PhD researchers.

Statistic 110

Global medical research workforce estimated at 7 million full-time equivalents in 2021.

Statistic 111

NIH-funded principal investigators numbered 18,000 in 2022.

Statistic 112

Women comprised 52% of U.S. biomedical postdocs in 2021.

Statistic 113

Clinical research coordinators: 25,000 certified by ACRP in 2023.

Statistic 114

Physician-scientists in U.S. declined to 10,000 MD-PhDs active in 2022.

Statistic 115

EU researcher mobility: 50,000 medical researchers via Marie Curie 2021-2027.

Statistic 116

UK had 45,000 clinical academics in NHS in 2022.

Statistic 117

China trained 300,000 new medical researchers annually by 2022.

Statistic 118

Diversity: Underrepresented minorities 12% of U.S. NIH PIs in 2022.

Statistic 119

Biostatisticians in pharma: 15,000 employed globally 2022.

Statistic 120

Nurse scientists: 20,000 in U.S. with research funding 2022.

Statistic 121

Patent examiners in biotech at USPTO: 500 specialized in 2023.

Statistic 122

Global CRO workforce hit 400,000 in 2022.

Statistic 123

Early-career researchers: 60% drop-out rate after PhD in biomed 2022.

Statistic 124

Japan: 100,000 medical researchers, 20% international.

Statistic 125

Australia: 12,000 NHMRC-funded researchers in 2022.

Statistic 126

Lab technicians in U.S. research: 150,000 FTEs 2021.

Statistic 127

IRBs: 5,000 U.S. institutional review boards with 50,000 members.

Statistic 128

Data scientists in medical research: 50,000 jobs posted 2022.

Statistic 129

Veteran researchers: 10% of U.S. biomedical workforce.

Statistic 130

Training grants: NIH supported 17,000 trainees in 2022.

Statistic 131

International postdocs in U.S.: 50% of 40,000 total postdocs.

Statistic 132

Pharmacoepidemiologists: 5,000 board-certified worldwide 2023.

Statistic 133

Medical physicists: 8,000 certified in U.S. for research 2022.

Statistic 134

Bioinformatics specialists grew 25% to 30,000 in U.S. 2022.

Statistic 135

Global health researchers from LMICs: 30% of total in 2022.

1/135

Sources

Trusted by 500+ publications

+497

Imagine a world where billions of dollars and the dedication of millions of scientists converge in a relentless quest to extend human life, a truth reflected in the staggering $238 billion spent globally on pharmaceutical R&D last year alone.

Key Takeaways

In fiscal year 2023, the U.S. National Institutes of Health (NIH) had a total budget of $47.7 billion, with $36.9 billion allocated directly to extramural research grants supporting over 50,000 competing and non-competing awards.
The global pharmaceutical R&D expenditure reached $238 billion in 2022, marking a 5.3% increase from the previous year, led by top 20 companies investing 19% of their sales revenue.
In 2021, the European Union allocated €95.5 billion to Horizon Europe, with €7.7 billion specifically for health cluster research including medical innovation.
In 2022, there were 4,568 clinical trials registered on ClinicalTrials.gov actively recruiting participants worldwide.
Phase III trials for oncology drugs averaged 1,200 patients per trial in 2021-2022, per FDA data.
COVID-19 vaccine trials enrolled over 150,000 participants across 40 Phase III studies by end of 2021.
In 2022, PubMed indexed 1.4 million biomedical research articles, up 4% from 2021.
Nature Medicine published 1,200 original research papers in 2022 on clinical advances.
Global scientific output in medical research grew to 2.5 million papers annually by 2023.
In 2022, U.S. had 120,000 biomedical PhD researchers.
Global medical research workforce estimated at 7 million full-time equivalents in 2021.
NIH-funded principal investigators numbered 18,000 in 2022.
U.S. medical research saved 100 million life-years from 1990-2020.
Cancer mortality dropped 33% in U.S. 1991-2022 due to research advances.
Vaccines prevented 154 million deaths globally 1974-2024.

Global medical research funding is vast, driving significant advances in treatments and saving countless lives.

Clinical Trials

In 2022, there were 4,568 clinical trials registered on ClinicalTrials.gov actively recruiting participants worldwide.
Phase III trials for oncology drugs averaged 1,200 patients per trial in 2021-2022, per FDA data.
COVID-19 vaccine trials enrolled over 150,000 participants across 40 Phase III studies by end of 2021.
In 2023, 1,200 new interventional trials for rare diseases were initiated globally.
U.S. FDA approved 37 novel drugs in 2022 from pivotal trials, 50% oncology.
Average duration of Phase II trials increased to 3.2 years in 2020-2022 due to complexity.
Over 90% of trials in 2022 used electronic data capture systems, reducing errors by 40%.
Diversity in trials: Only 8% of participants in CAR-T cell therapy trials were Black in 2017-2022.
Global trial sites numbered 200,000 in 2022, with 40% in North America.
Adaptive trial designs used in 15% of new oncology trials in 2022.
Pediatric trials: Only 12% of drugs approved 2012-2022 had pediatric-specific trials.
Decentralized trials grew to 20% of all trials in 2023, per Clinical Leader survey.
Alzheimer's trials failed at 99% rate over 20 years, with 200+ terminated by 2023.
mRNA platform trials accelerated: 10 vaccines in Phase III within 1 year for COVID.
In 2022, 2,500 trials focused on gene therapy, up 300% since 2015.
Trial recruitment time averaged 4.5 months in 2022, down 20% from 2019 via tech.
EU Clinical Trials Regulation: 4,800 trials authorized in first year post-2022.
Biosimilar trials: 150 ongoing in 2023 for monoclonal antibodies.
Heart failure trials: 500 active in 2023, focusing on SGLT2 inhibitors.
Only 5% of trials in low-income countries in 2022, per WHO.
AI predicted trial outcomes in 80% accuracy for 1,000+ trials in 2022 study.
Rheumatology trials: 300 Phase III in 2022 for JAK inhibitors.
Long COVID trials: 200 registered by mid-2023.
Precision medicine trials: 40% enrollment via biomarkers in oncology 2022.
Vaccine trials for HIV: 50 Phase II/III ongoing in 2023.

Clinical Trials Interpretation

We are casting a wider scientific net than ever, yet the glaring gaps in its weave—like stark inequities in participation and a stubborn resistance in fields like Alzheimer's—remind us that the quality of our evidence is only as robust as the diversity and design of the trials we create.

Funding

In fiscal year 2023, the U.S. National Institutes of Health (NIH) had a total budget of $47.7 billion, with $36.9 billion allocated directly to extramural research grants supporting over 50,000 competing and non-competing awards.
The global pharmaceutical R&D expenditure reached $238 billion in 2022, marking a 5.3% increase from the previous year, led by top 20 companies investing 19% of their sales revenue.
In 2021, the European Union allocated €95.5 billion to Horizon Europe, with €7.7 billion specifically for health cluster research including medical innovation.
Cancer research funding in the U.S. totaled $6.8 billion in 2022 from NIH, representing 13% of the total NIH extramural budget.
Venture capital investment in biotech reached $48.7 billion globally in 2021, a record high with 25% directed towards early-stage medical research firms.
The Wellcome Trust disbursed £1.2 billion in 2022 for medical research grants, focusing on infectious diseases and mental health.
U.S. federal funding for Alzheimer's disease research increased to $3.8 billion in FY2023, up 7% from prior year via NIH and other agencies.
Japan's Ministry of Health, Labour and Welfare budgeted ¥167.4 billion for medical research in 2022, emphasizing regenerative medicine.
Global R&D funding for rare diseases hit $4.5 billion in 2021 from public and private sources, per the EveryLife Foundation.
Bill & Melinda Gates Foundation committed $8.6 billion in 2022, with 40% to global health research including vaccines.
NIH's BRAIN Initiative received $712 million in FY2023 for neuroscience research funding.
UK Medical Research Council awarded £1.1 billion in 2022-23 for biomedical research across 5,000 projects.
China's National Natural Science Foundation funded ¥30.6 billion for health sciences in 2022.
Australian NHMRC invested AUD 1.2 billion in 2022 for medical research grants.
Howard Hughes Medical Institute provided $800 million annually for biomedical research investigators.
Global funding for COVID-19 research exceeded $100 billion by 2022, per WHO tracking.
U.S. DOD funded $1.5 billion for medical research in 2023, including trauma and infectious diseases.
Canada's CIHR budget was CAD 1.3 billion in 2022-23 for health research.
Germany's DFG allocated €3.8 billion total in 2022, with 25% to life sciences.
France's ANR funded €1.1 billion for research, 15% health-related in 2022.
Philanthropic funding for medical research in U.S. totaled $5.2 billion in 2021 from top 50 donors.
NIH diversity supplements awarded $100 million in 2022 to support underrepresented researchers.
ARPA-H launched with $1 billion initial funding in 2022 for high-risk medical research.
Swiss National Science Foundation allocated CHF 600 million for medicine in 2022.
India's DBT budgeted INR 4,500 crore for biotech and medical research in 2023-24.
South Korea's NRF funded KRW 2.5 trillion total, 20% health in 2022.
Brazil's CNPq invested BRL 1.2 billion for health research in 2022.
NIH's ORIP funded $200 million for animal models in research in FY2023.
Global venture funding for AI in drug discovery hit $5.1 billion in 2022.
U.S. states provided $2.3 billion in bonds for medical research facilities in 2022.

Funding Interpretation

The world is pouring hundreds of billions of dollars into health research every year, proving that while we can't seem to agree on much, we have a near-universal and expensive consensus that not dying would be really great.

Impact

U.S. medical research saved 100 million life-years from 1990-2020.
Cancer mortality dropped 33% in U.S. 1991-2022 due to research advances.
Vaccines prevented 154 million deaths globally 1974-2024.
HIV treatments extended life expectancy by 10 years post-1996 ART.
mRNA vaccines reduced COVID deaths by 20 million in first year.
Statins prevented 100,000 heart attacks annually worldwide by 2020.
CRISPR gene editing treated first sickle cell patient in 2023 trial.
Immunotherapy doubled 5-year survival for melanoma from 25% to 50% 2010-2022.
Global DALYs reduced 20% for infectious diseases 2000-2019 via research.
Alzheimer's research diagnostics improved detection by 90% accuracy.
Organoid models accelerated drug discovery, cutting costs 30%.
CAR-T therapy cured 50% pediatric leukemia cases post-2017.
Precision oncology matched therapies for 40% advanced cancers 2022.
Telemedicine research expanded access, reducing no-shows 25%.
Antibiotic stewardship programs cut resistance 17% in hospitals.
Mental health apps from research helped 20 million users 2022.
Regenerative medicine restored vision in 1,000 AMD patients via stem cells.
Big data analytics predicted outbreaks, saving $1B in response costs.
HPV vaccine prevented 90% cervical cancers in vaccinated cohorts.
Robotic surgery reduced complications 20% in 1 million procedures.
Microbiome research led to 10 new therapeutics in pipeline 2023.
AI diagnostics matched radiologists 95% accuracy, speeding reports 30%.
Rare disease research diagnosed 5,000 via genomics 2022.
Opioid crisis research cut overdose deaths 10% via naloxone.
Climate-health research informed policies averting 250,000 deaths by 2030.
Economic return: $1 NIH funding yields $2.21 health gains.

Impact Interpretation

While these numbers might read like science fiction, they are in fact the hard-won receipts of medical research, politely suggesting that funding it further is the ultimate no-brainer.

Publications

In 2022, PubMed indexed 1.4 million biomedical research articles, up 4% from 2021.
Nature Medicine published 1,200 original research papers in 2022 on clinical advances.
Global scientific output in medical research grew to 2.5 million papers annually by 2023.
Lancet journals issued 15,000 articles in 2022, with 30% on global health.
NEJM acceptance rate for original articles was 7.5% in 2022 from 5,000 submissions.
Open access medical papers reached 50% of total output in 2022, per DOAJ.
Citations to COVID-19 papers exceeded 1 million by 2022 in Web of Science.
JAMA Network published 4,500 research articles in 2022.
h-index for top medical journals averaged 250 in 2023 Scimago rankings.
Preprints in medRxiv totaled 45,000 in 2022, accelerating dissemination.
BMJ published 3,200 original research papers in 2022.
PLOS Medicine impact factor hit 11.1 in 2022 with 400 articles.
Cell journal family output: 800 medical papers in 2022.
Science Translational Medicine: 500 articles in 2022 on bench-to-bedside.
Annual Review of Pathology: 25 reviews in 2022 cited 10,000+ times.
Retractions in medical journals rose to 2,500 in 2022, per Retraction Watch.
Altmetric scores for top 100 medical papers averaged 1,500 in 2022.
Cochrane Reviews updated 1,000 systematic reviews in 2022.
Nature Reviews series published 2,000 review articles in medicine 2022.
UpToDate synthesized 12,000 medical topics from 8 million references in 2023.
Google Scholar indexed 10 million medical citations added in 2022.
Springer Nature medical portfolio: 25,000 chapters/books in 2022.
Elsevier's Lancet Digital Health: 300 articles on AI in 2022.
Citations per medical paper averaged 25 in 2022 Scopus data.
Women authored 45% of first-author papers in medical journals 2022.
Medical AI papers surged 300% to 15,000 in PubMed 2020-2022.
Global health papers: 100,000 in 2022, led by LMICs.

Publications Interpretation

While the sheer volume of medical literature has exploded to over 2.5 million papers annually, painting a portrait of frenetic and increasingly open scientific progress, its true utility will be judged not by the towering pile of publications but by our ability to distill it into genuine, equitable, and reliable clinical wisdom for the world.

Workforce

In 2022, U.S. had 120,000 biomedical PhD researchers.
Global medical research workforce estimated at 7 million full-time equivalents in 2021.
NIH-funded principal investigators numbered 18,000 in 2022.
Women comprised 52% of U.S. biomedical postdocs in 2021.
Clinical research coordinators: 25,000 certified by ACRP in 2023.
Physician-scientists in U.S. declined to 10,000 MD-PhDs active in 2022.
EU researcher mobility: 50,000 medical researchers via Marie Curie 2021-2027.
UK had 45,000 clinical academics in NHS in 2022.
China trained 300,000 new medical researchers annually by 2022.
Diversity: Underrepresented minorities 12% of U.S. NIH PIs in 2022.
Biostatisticians in pharma: 15,000 employed globally 2022.
Nurse scientists: 20,000 in U.S. with research funding 2022.
Patent examiners in biotech at USPTO: 500 specialized in 2023.
Global CRO workforce hit 400,000 in 2022.
Early-career researchers: 60% drop-out rate after PhD in biomed 2022.
Japan: 100,000 medical researchers, 20% international.
Australia: 12,000 NHMRC-funded researchers in 2022.
Lab technicians in U.S. research: 150,000 FTEs 2021.
IRBs: 5,000 U.S. institutional review boards with 50,000 members.
Data scientists in medical research: 50,000 jobs posted 2022.
Veteran researchers: 10% of U.S. biomedical workforce.
Training grants: NIH supported 17,000 trainees in 2022.
International postdocs in U.S.: 50% of 40,000 total postdocs.
Pharmacoepidemiologists: 5,000 board-certified worldwide 2023.
Medical physicists: 8,000 certified in U.S. for research 2022.
Bioinformatics specialists grew 25% to 30,000 in U.S. 2022.
Global health researchers from LMICs: 30% of total in 2022.

Workforce Interpretation

While celebrating a robust global ecosystem of over seven million dedicated minds, we must soberly acknowledge that this monumental medical research enterprise rests upon a precariously narrow foundation of principal investigators, is plagued by a hemorrhaging pipeline of early-career talent, and continues to struggle with representing the very populations it aims to serve.

Sources & References

Logos provided by Logo.dev